NYSE · Medical - Diagnostics & Research

Waters Corporation (WAT) Stock

$386.07 +4.01% NYSE: WAT Healthcare

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA.

Valuation

MetricValue
Price$386.07
Market Cap$25.17B
P/E Ratio30.60
P/B Ratio8.38
P/S Ratio5.79
EPS (TTM)$10.76
52-Week High$414.15
52-Week Low$275.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE25.11%
ROA12.66%
ROCE34.86%
Gross Margin28.21%
Operating Margin28.21%
Net Margin11.91%
Debt/Equity0.36
Current Ratio1.73

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.8B$3.0B$3.0B$3.0B$3.2B
Operating Profit$822.0M$873.0M$818.0M$826.0M$893.0M
Net Profit$693.0M$708.0M$642.0M$638.0M$643.0M
EPS$11.17$11.73$10.84$10.71$10.76
Op Margin29.5%29.4%27.7%27.9%28.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.1B$3.3B$4.6B$4.6B$5.1B
Total Liabilities$2.7B$2.8B$3.5B$2.7B$2.5B
Cash$501.0M$481.0M$395.0M$324.0M$588.0M
Borrowings$1.6B$1.7B$2.4B$1.7B$1.5B

Latest News

WAT: Lowering target price to $404.00 Argus Research · Jul 22, 2026 Q1 Research Tools & Consumables Earnings Review: First Prize Goes to Waters Corporation (NYSE:WAT) StockStory · Jul 17, 2026 TD Cowen Adjusts Price Target on Waters to $408 From $385, Keeps Hold Rating MT Newswires · Jul 15, 2026 Goldman Sachs Adjusts Price Target on Waters to $425 From $380, Maintains Buy Rating MT Newswires · Jul 14, 2026 Waters Corporation's Quarterly Earnings Preview: What You Need to Know Barchart · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$747.0M$612.0M$603.0M$762.0M$653.0M
Investing Cash Flow$-400.0M$-291.0M$-1.6B$-287.0M$-265.0M
Financing Cash Flow$-598.0M$-570.0M$-25.0M$33.0M$-15.0M
Net Cash Flow$65.0M$-21.0M$-85.0M$-71.0M$262.0M
Free Cash Flow$579.0M$428.0M$442.0M$620.0M$540.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA20.35
FCF Yield1.21%
Quick Ratio1.13
Interest Coverage17.51
Return 1Y30.49%
Return 3Y27.30%
Return 5Y-2.55%

Ownership

Insiders Held0.10%
Institutions Held99.99%
Institutions Float Held100.10%
Institutional HolderSharesReport Date
Blackrock Inc.8,543,0142026-03-31
Vanguard Capital Management LLC6,378,7752026-03-31
Vanguard Portfolio Management LLC4,754,1852026-03-31
T. Rowe Price Investment Management, Inc.4,663,8792026-03-31
Massachusetts Financial Services Co.4,630,1182026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DGXQuest Diagnostics Incorporated $235.90 +1.75% 21.70 $26.04B 1.68%
DXCMDexCom, Inc. $73.51 +2.75% 26.01 $28.37B 0.00%
ILMNIllumina, Inc. $189.61 -2.31% 26.54 $28.69B 0.00%
INCYIncyte Corporation $129.03 +8.55% 14.00 $25.78B 0.00%
LHLabcorp Holdings Inc. $314.14 +4.31% 24.43 $25.76B 1.12%

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Waters Corporation is led by CEO Udit Batra, employs 7,900 people, headquartered in Milford, US, publicly traded since 1995.

Waters Corporation (WAT) stock trades at $386.07 with a market capitalization of $25.17B. The stock is valued at a price-to-earnings (P/E) ratio of 30.60, price-to-book of 8.38, price-to-sales of 5.79. Over the past 52 weeks the stock has ranged between $275.05 and $414.15, and currently trades 6.8% below its 52-week high.

On profitability, Waters Corporation generates a return on equity (ROE) of 25.11% — well above the market average, a sign of a high-quality business, return on capital employed of 34.86%, an operating margin of 28.21%, a net profit margin of 11.91%.

In its most recent fiscal year, Waters Corporation reported annual revenue of $3.2B, net profit of $643.0M, revenue has compounded at 6.0% a year over the last five years, profit at 4.3% a year.

The balance sheet shows a debt-to-equity ratio of 0.36 — a conservative balance sheet with little leverage risk, a current ratio of 1.73, total assets of $5.1B, $588.0M in cash and equivalents.

WAT has an average daily trading volume of 1,000,124 shares, a beta of 1.20.

Official website: www.waters.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides